Sleep Disorders Trial, Recruiting (NCT07476937)

Sleep Disorders Trial, Recruiting NCT07476937 Sponsor: University of Pittsburgh Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT07476937 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children between the ages of 6 and 10 years old
Children whose caregiver has reported an autism diagnosis, and who score above 11 on a standard social communication questionnaire
Children whose caregiver has reported bedtime resistance, with a score above 12 on a specific sleep habits questionnaire designed for autistic children
A caregiver who is willing and able to be present at every bedtime throughout the study
Children whose medication use has been stable, meaning no changes in the past 2 weeks or more

Who may not be able to join:

Children who do not understand English, or whose family is unable to travel to the study location in Pittsburgh, PA
Children who have also been diagnosed with sleep apnea, narcolepsy, or a major psychiatric condition such as major depression or bipolar disorder
Children whose medication dose or timing is not currently stable
Children who are currently receiving a behavioural treatment for a sleep disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amy G Hartman, PhD, University of Pittsburgh

Phone: 412-648-7997

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07476937

Sponsor: University of Pittsburgh

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: 412-648-7997

More information: https://clinicaltrials.gov/study/NCT07476937

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children between the ages of 6 and 10 years old
Children whose caregiver has reported an autism diagnosis, and who score above 11 on a standard social communication questionnaire
Children whose caregiver has reported bedtime resistance, with a score above 12 on a specific sleep habits questionnaire designed for autistic children
A caregiver who is willing and able to be present at every bedtime throughout the study
Children whose medication use has been stable, meaning no changes in the past 2 weeks or more

Who may not be able to join:

Children who do not understand English, or whose family is unable to travel to the study location in Pittsburgh, PA
Children who have also been diagnosed with sleep apnea, narcolepsy, or a major psychiatric condition such as major depression or bipolar disorder
Children whose medication dose or timing is not currently stable
Children who are currently receiving a behavioural treatment for a sleep disorder

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Pittsburgh

Registry

ClinicalTrials.gov

Start date

20 July 2026

Est. completion

1 July 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Nightly emotion dysregulation; Bedtime sensory over-responsivity; Sleep onset latency

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov